查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594559

肥胖治療市場：按藥物、手術、設備分類 - 全球預測 2025-2030

Obesity Treatment Market by Drugs, Surgery & Devices - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年肥胖治療市值為171.4億美元，預計到2024年將達到188.8億美元，複合年成長率為10.24%，到2030年將達到339.3億美元。

肥胖治療包括各種幫助個人達到並維持健康體重的介入措施，包括改變生活方式、藥物和手術選擇。對有效肥胖治療的需求源於全球肥胖盛行率的不斷上升，肥胖帶來了重大的健康風險，如糖尿病、心血管疾病和某些癌症。應用程式涵蓋醫療保健提供者、健康計劃和公共衛生舉措，最終用戶範圍從個別患者到大型醫療保健組織。該領域的市場成長主要得益於人們對肥胖相關健康問題的認知不斷提高、治療方法的進步以及政府的支持政策。主要影響因素包括醫療設備的技術創新、新藥的開發以及行動醫療應用程式和遠端醫療服務等數位健康解決方案的進一步整合。最近的一個潛在治療機會在於個人化醫療方法，利用遺傳見解來制定量身定做的治療計劃。然而，該行業面臨治療成本上升、監管障礙以及與肥胖相關的社會恥辱等挑戰。也存在一些限制，例如某些地區獲得醫療保健的機會有限以及患者對治療的依從性不一致。最佳創新領域包括開發非侵入性治療方法、先進的行為治療技術以及跨部門夥伴關係以增強患者參與和結果追蹤。該市場是動態的、多元化的，其特點是技術創新迅速、競爭激烈。公司必須應對監管的複雜性，並專注於具有成本效益的解決方案，以確保市場滲透。為了利用新機遇，企業必須投資持續的研發，採用數位轉型策略，並與公共衛生機構合作以擴大其覆蓋範圍和影響力。解決這些因素可以顯著提高治療效果和患者的生活品質，同時確保長期的市場成功。

主要市場統計
基準年[2023] 171.4億美元
預測年份 [2024] 188.8億美元
預測年份 [2030] 339.3億美元
複合年成長率（%） 10.24%

市場動態：揭示快速發展的肥胖治療市場的關鍵市場洞察

供需的動態交互作用正在改變肥胖治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球肥胖人口不斷增加
    • 體重管理和健身意識不斷增強
    • 減重手術數量增加
  • 市場限制因素
    • 產品召回與處理成本上升
  • 市場機會
    • 減重手術設備的技術進步
    • 新型微創手術研究
  • 市場挑戰
    • 與治療藥物相關的風險、併發症和副作用

波特五力：駕馭肥胖治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解肥胖治療市場的外在影響

外部宏觀環境因素在塑造肥胖治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解肥胖治療市場的競爭格局

對肥胖治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣肥胖治療市場供應商的績效評估

FPNV定位矩陣是評估肥胖治療市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃肥胖治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對肥胖治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球肥胖盛行率
      • 體重管理和健身意識不斷增強
      • 減重手術增加
    • 抑制因素
      • 產品召回和高額的處理成本
    • 機會
      • 減重手術設備的技術進步
      • 新微創減重手術的研究
    • 任務
      • 與治療相關的風險、併發症和副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 藥物肥胖治療市場

  • 食慾抑制劑
  • 伴隨藥物
  • 吸收不良和飽足感藥物

第7章肥胖治療市場手術與設備

  • 可調式胃束帶
  • 十二指腸轉管膽胰繞道手術
  • 內視鏡手術
  • 胃繞道手術手術
  • 袖狀切除術

第8章北美與南美肥胖治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區肥胖治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的肥胖治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Apollo Endosurgery, Inc.
  • Atkins Nutritionals, Inc.
  • BTL Aesthetics
  • CH Boehringer Sohn AG & Ko. KG
  • Herbalife Ltd.
  • Johnson & Johnson Services, Inc.
  • Kellogg Company
  • Medtronic PLC
  • Novo Nordisk A/S
  • NutriSystem, Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • ReShape Lifesciences, Inc.
  • Vivus, Inc.
Product Code: MRR-EC2E133E32E2

The Obesity Treatment Market was valued at USD 17.14 billion in 2023, expected to reach USD 18.88 billion in 2024, and is projected to grow at a CAGR of 10.24%, to USD 33.93 billion by 2030.

Obesity treatment encompasses a range of interventions designed to help individuals achieve and maintain a healthy weight, including lifestyle changes, pharmacotherapy, and surgical options. The necessity for effective obesity treatment arises from the growing global prevalence of obesity, which poses significant health risks such as diabetes, cardiovascular diseases, and certain cancers. The applications extend across healthcare providers, wellness programs, and public health initiatives, with end-users ranging from individual patients to large health organizations. Market growth in this sector is primarily driven by increasing awareness of obesity-related health issues, advancements in medical treatments, and supportive government policies. Key influencing factors include technological innovations in medical devices, the development of new pharmaceuticals, and the increasing integration of digital health solutions like mobile health apps and telehealth services. Recent potential opportunities lay in personalized medicine approaches, leveraging genetic insights to design tailored treatment plans. However, the industry faces challenges such as the high cost of treatments, regulatory hurdles, and societal stigma associated with obesity. Limitations include limited access to healthcare in some regions and inconsistent treatment adherence among patients. The best areas for innovation include the development of non-invasive treatment modalities, advanced behavioral therapy techniques, and cross-sector partnerships to enhance patient engagement and outcome tracking. The market is dynamic and multifaceted, characterized by rapid technological innovations and a highly competitive landscape. Companies must navigate regulatory complexities and focus on cost-effective solutions to ensure market penetration. To capitalize on emerging opportunities, businesses should invest in continuous research and development, embrace digital transformation strategies, and collaborate with public health agencies to expand their reach and impact. Addressing these factors can potentially lead to significant improvements in treatment efficacy and patient quality of life while securing long-term market success.

KEY MARKET STATISTICS
Base Year [2023] USD 17.14 billion
Estimated Year [2024] USD 18.88 billion
Forecast Year [2030] USD 33.93 billion
CAGR (%) 10.24%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Obesity Treatment Market

The Obesity Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of obese population worldwide
    • Growing awareness regarding weight management and fitness
    • Growing number of bariatric surgeries
  • Market Restraints
    • Product recall and high cost of treatment
  • Market Opportunities
    • Technological advancements in obesity surgery devices
    • Research about new minimally invasive obesity treatment procedures
  • Market Challenges
    • Associated risks, complications and side effects of treatment therapeutics

Porter's Five Forces: A Strategic Tool for Navigating the Obesity Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Obesity Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Obesity Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Obesity Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Obesity Treatment Market

A detailed market share analysis in the Obesity Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Obesity Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Obesity Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Obesity Treatment Market

A strategic analysis of the Obesity Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Obesity Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Apollo Endosurgery, Inc., Atkins Nutritionals, Inc., BTL Aesthetics, C.H. Boehringer Sohn AG & Ko. KG, Herbalife Ltd., Johnson & Johnson Services, Inc., Kellogg Company, Medtronic PLC, Novo Nordisk A/S, NutriSystem, Inc., Olympus Corporation, Pfizer, Inc., ReShape Lifesciences, Inc., and Vivus, Inc..

Market Segmentation & Coverage

This research report categorizes the Obesity Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drugs, market is studied across Appetite Suppressants, Combination Drugs, and Malabsorption & Satiety Drugs.
  • Based on Surgery & Devices, market is studied across Adjustable Gastric Banding, Biliopancreatic Diversion With Duodenal Switch, Endoscopic Procedures, Roux-en-Y Gastric Bypass, and Sleeve Gastrectomy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of obese population worldwide
      • 5.1.1.2. Growing awareness regarding weight management and fitness
      • 5.1.1.3. Growing number of bariatric surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall and high cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in obesity surgery devices
      • 5.1.3.2. Research about new minimally invasive obesity treatment procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Associated risks, complications and side effects of treatment therapeutics
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Obesity Treatment Market, by Drugs

  • 6.1. Introduction
  • 6.2. Appetite Suppressants
  • 6.3. Combination Drugs
  • 6.4. Malabsorption & Satiety Drugs

7. Obesity Treatment Market, by Surgery & Devices

  • 7.1. Introduction
  • 7.2. Adjustable Gastric Banding
  • 7.3. Biliopancreatic Diversion With Duodenal Switch
  • 7.4. Endoscopic Procedures
  • 7.5. Roux-en-Y Gastric Bypass
  • 7.6. Sleeve Gastrectomy

8. Americas Obesity Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Obesity Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Obesity Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Apollo Endosurgery, Inc.
  • 3. Atkins Nutritionals, Inc.
  • 4. BTL Aesthetics
  • 5. C.H. Boehringer Sohn AG & Ko. KG
  • 6. Herbalife Ltd.
  • 7. Johnson & Johnson Services, Inc.
  • 8. Kellogg Company
  • 9. Medtronic PLC
  • 10. Novo Nordisk A/S
  • 11. NutriSystem, Inc.
  • 12. Olympus Corporation
  • 13. Pfizer, Inc.
  • 14. ReShape Lifesciences, Inc.
  • 15. Vivus, Inc.

LIST OF FIGURES

  • FIGURE 1. OBESITY TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. OBESITY TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OBESITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OBESITY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. OBESITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. OBESITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OBESITY TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OBESITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OBESITY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OBESITY TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OBESITY TREATMENT MARKET SIZE, BY APPETITE SUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OBESITY TREATMENT MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OBESITY TREATMENT MARKET SIZE, BY MALABSORPTION & SATIETY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OBESITY TREATMENT MARKET SIZE, BY BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ROUX-EN-Y GASTRIC BYPASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SLEEVE GASTRECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. OBESITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. OBESITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023